Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 02:49PM ET
1.39
Dollar change
-0.05
Percentage change
-3.47
%
IndexRUT P/E- EPS (ttm)-0.97 Insider Own1.58% Shs Outstand150.07M Perf Week13.02%
Market Cap208.61M Forward P/E- EPS next Y-0.38 Insider Trans117.95% Shs Float147.71M Perf Month75.76%
Income-119.70M PEG- EPS next Q-0.15 Inst Own78.77% Short Float / Ratio11.91% / 5.98 Perf Quarter7.76%
Sales122.84M P/S1.70 EPS this Y44.76% Inst Trans6.29% Short Interest17.59M Perf Half Y16.82%
Book/sh-0.20 P/B- EPS next Y58.54% ROA-47.77% Target Price5.62 Perf Year-43.49%
Cash/sh0.52 P/C2.69 EPS next 5Y47.50% ROE-2408.88% 52W Range0.50 - 3.41 Perf YTD-44.40%
Dividend- P/FCF- EPS past 5Y14.46% ROI-80.22% 52W High-59.23% Beta1.54
Dividend %- Quick Ratio1.91 Sales past 5Y44.61% Gross Margin44.77% 52W Low178.02% ATR0.15
Employees203 Current Ratio2.43 Sales Q/Q18.36% Oper. Margin-98.30% RSI (14)63.69 Volatility12.64% 16.77%
OptionableYes Debt/Eq- EPS Q/Q54.01% Profit Margin-97.45% Rel Volume0.47 Prev Close1.44
ShortableYes LT Debt/Eq- EarningsNov 14 AMC Payout- Avg Volume2.94M Price1.39
Recom1.00 SMA2026.42% SMA5052.97% SMA200-8.40% Volume1,152,616 Change-3.47%
Date Action Analyst Rating Change Price Target Change
May-27-20Initiated Guggenheim Buy $24
Feb-20-20Reiterated Needham Buy $50 → $48
Jan-16-19Reiterated Needham Buy $66 → $64
Apr-05-18Initiated Evercore ISI Outperform $56
Mar-19-18Reiterated Mizuho Buy $28 → $35
Mar-01-18Reiterated Needham Buy $28 → $30
Jan-03-18Initiated Leerink Partners Outperform $22
Sep-27-17Initiated Northland Capital Outperform $40
Feb-27-17Initiated Needham Buy $28
Oct-26-16Initiated Aegis Capital Buy
Dec-06-23 11:55AM
Nov-28-23 07:33PM
Nov-15-23 10:17AM
08:51AM
08:46AM
06:00PM Loading…
Nov-14-23 06:00PM
04:17PM
04:05PM
Nov-07-23 04:05PM
Aug-24-23 09:29AM
Aug-15-23 01:30PM
12:48PM
09:47AM
Aug-14-23 04:29PM
04:05PM
04:05PM Loading…
Aug-07-23 04:05PM
10:50AM
Jul-26-23 01:30PM
Jul-24-23 09:02AM
09:00AM
Jun-23-23 04:05PM
Jun-12-23 09:00AM
May-11-23 05:15PM
04:12PM
04:01PM
May-05-23 12:28PM
Apr-20-23 11:45AM
09:00AM
Apr-17-23 04:05PM
Apr-06-23 03:42PM
02:01PM Loading…
02:01PM
Apr-03-23 09:00AM
Mar-27-23 07:12AM
Mar-24-23 06:43AM
Mar-23-23 09:28PM
05:35PM
04:05PM
Mar-13-23 09:00AM
Mar-10-23 04:05PM
Mar-06-23 09:00AM
Feb-27-23 04:30PM
Feb-22-23 09:00AM
Jan-30-23 05:54AM
Jan-09-23 08:30AM
Dec-29-22 09:45AM
09:00AM
Dec-28-22 12:32PM
Dec-20-22 03:41PM
Nov-21-22 04:05PM
Nov-15-22 10:14PM
Nov-10-22 05:44AM
Nov-09-22 01:15PM
Nov-08-22 06:25PM
04:05PM
Nov-04-22 11:48AM
Nov-01-22 04:05PM
Sep-26-22 09:45AM
Sep-23-22 09:19AM
07:30AM
Sep-19-22 06:42AM
Sep-16-22 02:49PM
Sep-12-22 07:37AM
Aug-23-22 12:00PM
Aug-15-22 09:55AM
Aug-09-22 02:10PM
09:15AM
08:01AM
08:00AM
Aug-02-22 04:05PM
Jul-21-22 06:32AM
Jul-18-22 06:00PM
Jun-30-22 08:41AM
08:30AM
Jun-14-22 08:30AM
May-26-22 04:05PM
May-16-22 04:05PM
May-09-22 06:45PM
04:05PM
May-03-22 04:05PM
Apr-05-22 04:05PM
Mar-28-22 03:14PM
Mar-25-22 08:30AM
Mar-17-22 08:30AM
Mar-04-22 04:00PM
Mar-02-22 04:05PM
Mar-01-22 03:38PM
Feb-28-22 05:45PM
04:05PM
Feb-24-22 03:49PM
Feb-22-22 04:05PM
Feb-11-22 07:25AM
Feb-07-22 09:38AM
Feb-02-22 01:38PM
Jan-19-22 01:38PM
Jan-03-22 09:38PM
Dec-09-21 04:19PM
12:32PM
10:00AM
08:00AM
Dec-06-21 01:42PM
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Forbes William PEVP, Chief Development OfficerNov 17Buy1.0925,00027,25079,000Nov 21 12:19 PM
Collard Craig AChief Executive OfficerNov 16Buy0.92150,000137,970186,496Nov 17 12:37 PM
Duarte IraEVP, Chief Financial OfficerNov 16Buy0.8985,00075,59985,000Nov 17 12:36 PM
Forbes William PEVP, Chief Development OfficerNov 16Buy0.9450,00046,99554,000Nov 20 10:07 AM
Morgan AdamDirectorJul 21Buy1.372,486,7443,406,8396,986,744Jul 25 04:22 PM